Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6182593 | Gynecologic Oncology | 2016 | 4 Pages |
Abstract
LT survivors of HGSC of the ovary generally have favorable clinical features including optimal surgical cytoreduction and primary platinum sensitive disease. The majority of patients will develop recurrent disease, however many remained disease free for more than 10Â years. Future work will compare the clinical features of this unusual cohort of LT survivors with the characteristics of HGSC patients having less favorable outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Fanny Dao, Brooke A. Schlappe, Jill Tseng, Jenny Lester, Alpa M. Nick, Susan K. Lutgendorf, Scott McMeekin, Robert L. Coleman, Kathleen N. Moore, Beth Y. Karlan, Anil K. Sood, Douglas A. Levine,